CLINICAL_TRIALS
trial_result
· 2017-05-05
Clinical Trial Update: Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED) [Phase 3]
Summary
A Phase 3 trial evaluating MK0869 for major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED